
AOD-9604 is a 16-amino-acid synthetic peptide based on the C-terminal fragment of human growth hormone, designed to isolate that region's lipolytic activity from GH's growth and IGF-1 effects. Research has linked its mechanism to β3-adrenergic signaling. Its pharmaceutical development ended after a pivotal trial missed its primary efficacy endpoint, and it is not approved for any indication.
Price range: $50.00 through $85.00
For laboratory research use only. Not for human consumption.